NCT05242861Recruiting
Retrospective Study of Brachytherapy
A Retrospective Study of Brachytherapy in Gynecological Cancers
Source: ClinicalTrials.gov · Last updated 16 Feb 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Brachytherapy for gynecological cancers will be studied retrospectively.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 6 Feb 2022
- Start date
- 20 Feb 2022
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Zhejiang Cancer Hospital
- Diseases
- Endometrial cancer, Cervical cancer, Ovarian cancer
- NCT number
- NCT05242861
What you commit to
- Study type: Observational
- Planned participants: 300
- From 20 Feb 2022 to the primary completion date, 31 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Refusal to enter this trial
Who the study is looking for
- 18 - 80 female
- Underwent brachytherapy
- With gynecological cancer
Age in the registry: 18 years to 80 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zhejiang Cancer Hospital Coordinator of this site? Confirm its status | Hangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.